Young Blood and Plasma Transfusions
Young Blood and Plasma Transfusions
The FDA recently warned that plasma infusions from young people provides “no proven clinical benefit” against normal aging, Alzheimer’s disease, or a host of other diseases.
Directors Gottlieb and Marks from the Center for Biologics Evaluation and Research say young-blood transfusions can pose risks.
Most research thus far into young-blood transfusions has been conducted in mice. Some of the mouse studies have been encouraging, but other studies have been less encouraging. One biotech company is currently testing a plasma-derived product in Alzheimer’s patients; a previous study from the company yielded mixed results.